TriSalus Life Sciences (TLSI) Other Non Operating Income (2022 - 2026)

TriSalus Life Sciences' Other Non Operating Income history runs 5 years deep, the most recent figure standing at -$76000.0 for Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 69.72% year-over-year to -$76000.0 in Q1 2026; TTM through Mar 2026 was -$281000.0, a 31.46% increase from a year earlier, with the FY2025 full-year figure at -$456000.0, down 46.15% from the prior year.
• Other Non Operating Income eased to -$76000.0 in Q1 2026 per TLSI's latest filing, from -$71000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $881000.0 in Q1 2023 and bottomed at -$3.4 million in Q2 2023.
• The 5-year median for Other Non Operating Income is -$73500.0 (2025), against an average of -$393928.6.
• Across the five-year window, Other Non Operating Income soared 161.29% in 2023 and sank 623.08% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at -$2.1 million in 2022, then soared by 100.9% to $19000.0 in 2023, then plunged by 636.84% to -$102000.0 in 2024, then soared by 30.39% to -$71000.0 in 2025, then fell by 7.04% to -$76000.0 in 2026.
• Per Business Quant, the three latest TLSI Other Non Operating Income figures stand at -$76000.0 (Q1 2026), -$71000.0 (Q4 2025), and -$94000.0 (Q3 2025).